Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Client Area Book a 7-day Readout
Pascal Biosciences Inc. logo — Advancing targeted therapies for the treatment of cancer

Pascal Biosciences Inc.

Advancing targeted therapies for the treatment of cancer

Founded 2013 United States Seattle, United States 1 employees Grant Biotechnology

General Information

Company Name Pascal Biosciences Inc.
Founded Year 2013
Location United States Seattle, United States
Employees 1
Industries Biotechnology
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Pascal Biosciences Inc. . To contact Pascal Biosciences Inc. , visit pascalbiosciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Pascal Biosciences Inc. compare?

A PDF of Pascal Biosciences Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Pascal Biosciences Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Pascal Biosciences Inc.

Pascal Biosciences Inc. is a biotechnology company that is dedicated to advancing innovative approaches for the treatment of cancer through its development of cannabinoid-based therapeutics and targeted therapies. The company's leading cannabinoid portfolio includes ST-403, a small molecule therapeutic that is moving into clinical trials to address glioblastoma, along with an immuno-stimulatory molecule. Additionally, Pascal Biosciences is working on a B-cell targeted antibody for acute lymphoblastic leukemia and an antibody targeting calcium channels expressed by the immune system. Based in Vancouver, Canada, Pascal Biosciences trades on the TSX Venture Exchange under the symbol “PAS”. Since its establishment in 2013, the company has positioned itself at the forefront of the biotechnology industry, particularly in the field of cancer treatment. Currently, there is no information available regarding the company's last investment or the investors associated with it. With its emphasis on pioneering therapies for cancer, Pascal Biosciences Inc. stands out as a promising player in the biotechnology sector, with its sights set on transforming the landscape of cancer treatment.

No funding data available for Pascal Biosciences Inc. yet.

Pascal Biosciences Inc. Alternatives & Competitors

View All Alternatives
Pascal Biosciences Inc. vs
Trillium Therapeutics Inc.
Trillium Therapeutics Inc. United States

Clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer.

Post-IPO Equity
14 employees
Biopharma, Biotechnology
Pascal Biosciences Inc. vs
Prescient Therapeutics
Prescient Therapeutics Australia

A clinical stage oncology company developing personalised medicine approaches to cancer; cellular &...

Post-IPO Equity
14 employees
Biopharma, Biotechnology
Pascal Biosciences Inc. vs
Polymed Biopharmaceuticals
Polymed Biopharmaceuticals China

Polymed creates novel PROTAC therapies for cancers and immunology HPB-143 (IRAK4) & HPB-092 (FLT3/...

Series A
2 employees
Biotechnology, Pharmaceutical
View all alternatives

FAQ About Pascal Biosciences Inc.

Advancing targeted therapies for the treatment of cancer
Pascal Biosciences Inc. was founded in 2013.
Pascal Biosciences Inc. is headquartered in Seattle, United States.
Pascal Biosciences Inc. operates in Biotechnology.
Pascal Biosciences Inc. has approximately 1 employees.
Top alternatives and competitors to Pascal Biosciences Inc. include Trillium Therapeutics Inc., Prescient Therapeutics, Polymed Biopharmaceuticals, Actinium Pharmaceuticals, Inc., TME Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pascal Biosciences Inc. and Trillium Therapeutics Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pascal Biosciences Inc. , https://bouncewatch.com/company/pascal-biosciences-inc, updated 23 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout